PDB Short entry for 1QA7 HEADER HYDROLASE/HYDROLASE INHIBITOR 15-APR-99 1QA7 TITLE CRYSTAL COMPLEX OF THE 3C PROTEINASE FROM HEPATITIS A VIRUS WITH ITS TITLE 2 INHIBITOR AND IMPLICATIONS FOR THE POLYPROTEIN PROCESSING IN HAV COMPND MOL_ID: 1; COMPND 2 MOLECULE: HAV 3C PROTEINASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: HAV 3C PROTEINASE; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: PROTEINASE CHEMICALLY BONDED TO INHIBITOR ACE-VAL-NFA. COMPND 8 IT WAS CHEMICALLY SYNTHESIZED AS IODOACETYL-VALYL-PHENYLALANYL AMIDE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS A VIRUS; SOURCE 3 ORGANISM_TAXID: 12092; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PHAV3-CEX KEYWDS CHYMOTRYPSIN-LIKE CYSTEINE PROTEINASE VIRAL PROTEASE P'-SITE KEYWDS 2 INHIBITOR, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.M.BERGMANN,M.M.CHERNEY,J.MCKENDRICK,J.C.VEDERAS,M.N.G.JAMES REVDAT 11 16-AUG-23 1QA7 1 REMARK REVDAT 10 03-NOV-21 1QA7 1 REMARK SEQADV LINK REVDAT 9 16-MAY-12 1QA7 1 HET HETATM REVDAT 8 13-JUL-11 1QA7 1 VERSN REVDAT 7 03-NOV-09 1QA7 1 JRNL KEYWDS REMARK SEQADV REVDAT 6 24-FEB-09 1QA7 1 VERSN REVDAT 5 01-APR-03 1QA7 1 JRNL REVDAT 4 15-MAY-00 1QA7 1 REMARK REVDAT 3 23-FEB-00 1QA7 1 REMARK DBREF SEQADV REVDAT 2 24-JAN-00 1QA7 1 JRNL REVDAT 1 20-APR-99 1QA7 0 JRNL AUTH E.M.BERGMANN,M.M.CHERNEY,J.MCKENDRICK,S.FRORMANN,C.LUO, JRNL AUTH 2 B.A.MALCOLM,J.C.VEDERAS,M.N.JAMES JRNL TITL CRYSTAL STRUCTURE OF AN INHIBITOR COMPLEX OF THE 3C JRNL TITL 2 PROTEINASE FROM HEPATITIS A VIRUS (HAV) AND IMPLICATIONS FOR JRNL TITL 3 THE POLYPROTEIN PROCESSING IN HAV. JRNL REF VIROLOGY V. 265 153 1999 JRNL REFN ISSN 0042-6822 JRNL PMID 10603326 JRNL DOI 10.1006/VIRO.1999.9968 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.M.BERGMANN,S.C.MOSIMANN,M.M.CHERNAIA,B.A.MALCOLM, REMARK 1 AUTH 2 M.N.G.JAMES REMARK 1 TITL THE REFINED CRYSTAL STRUCTURE OF THE 3C GENE PRODUCT FROM REMARK 1 TITL 2 HEPATITIS A VIRUS: SPECIFIC PROTEINASE ACTIVITY AND RNA REMARK 1 TITL 3 RECOGNITION REMARK 1 REF J.VIROL. V. 71 2436 1997 REMARK 1 REFN ISSN 0022-538X REMARK 1 REFERENCE 2 REMARK 1 AUTH E.M.BERGMANN REMARK 1 TITL HEPATITIS A VIRUS PICORNAIN 3C REMARK 1 REF HANDBOOK OF PROTEOLYTIC 709 1998 REMARK 1 REF 2 ENZYMES REMARK 1 REFERENCE 3 REMARK 1 AUTH E.M.BERGMANN,M.N.G.JAMES REMARK 1 TITL THE 3C PROTEINASES OF PICORNAVIRUSES AND OTHER REMARK 1 TITL 2 POSITIVE-SENSE, SINGLE-STRANDED RNA VIRUSES REMARK 1 REF HANDBOOK OF EXP. PHARMACOL., 1999 REMARK 1 REF 2 VOL. PROTEASES AS TARGETS REMARK 1 REF 3 FOR THERAPY REMARK 1 REFERENCE 4 REMARK 1 AUTH B.A.MALCOLM,S.M.CHIN,D.A.JEWELL,J.R.STRATTON-THOMAS, REMARK 1 AUTH 2 K.THUDIUM REMARK 1 TITL EXPRESSION AND CHARACTERIZATION OF RECOMBINANT HEPATITIS A REMARK 1 TITL 2 VIRUS 3C PROTEINASE REMARK 1 REF BIOCHEMISTRY V. 31 3358 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 5E REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 55982 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.500 REMARK 3 FREE R VALUE TEST SET COUNT : 3902 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2140 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 55982 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6616 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 514 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 32.000 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.012 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 1.420 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : ENGH & HUBER REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NO NON-CRYSTALLOGRAPHIC RESTRAINTS REMARK 4 REMARK 4 1QA7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-99. REMARK 100 THE DEPOSITION ID IS D_1000009037. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59384 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.03300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.15700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ID 1HAV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS, 5% DMSO, 18% PEG 8000 , PH REMARK 280 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.17850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 214 REMARK 465 LYS A 215 REMARK 465 ILE A 216 REMARK 465 GLU A 217 REMARK 465 LYS C 214 REMARK 465 LYS C 215 REMARK 465 ILE C 216 REMARK 465 GLU C 217 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS D 147 O HOH D 4100 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 217 C GLU B 217 OXT 2.594 REMARK 500 GLU D 217 C GLU D 217 OXT 3.788 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASN B 148 N - CA - C ANGL. DEV. = 17.3 DEGREES REMARK 500 GLY B 150 N - CA - C ANGL. DEV. = -19.0 DEGREES REMARK 500 LEU C 113 CA - CB - CG ANGL. DEV. = 16.4 DEGREES REMARK 500 ARG D 10 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 29 -154.91 -168.73 REMARK 500 LYS A 35 148.57 172.90 REMARK 500 ASP A 36 -132.07 60.44 REMARK 500 ALA A 82 -84.79 -15.58 REMARK 500 GLN A 83 73.31 88.17 REMARK 500 THR A 121 -157.85 -133.89 REMARK 500 ASN A 124 80.90 13.98 REMARK 500 HIS A 145 -154.61 -142.00 REMARK 500 LYS A 147 117.32 177.63 REMARK 500 ASN A 211 45.08 -89.89 REMARK 500 ILE A 212 -59.77 -120.31 REMARK 500 MET B 29 -158.61 -167.08 REMARK 500 LYS B 35 149.13 -178.45 REMARK 500 ASP B 36 -121.78 51.24 REMARK 500 GLU B 53 -102.05 -50.43 REMARK 500 MET B 54 59.96 -90.80 REMARK 500 ALA B 82 10.26 -67.94 REMARK 500 GLN B 83 113.59 39.94 REMARK 500 THR B 121 -154.66 -139.27 REMARK 500 GLU B 132 -158.68 -142.39 REMARK 500 LYS B 147 -60.86 -149.55 REMARK 500 ASP B 149 -77.02 -59.71 REMARK 500 GLN B 159 71.08 42.73 REMARK 500 SER B 197 15.59 57.45 REMARK 500 LYS C 35 161.43 173.90 REMARK 500 ASP C 36 -125.85 51.12 REMARK 500 ASP C 79 -101.64 -137.20 REMARK 500 VAL C 80 -81.42 -57.96 REMARK 500 ASN C 124 84.64 46.34 REMARK 500 HIS C 145 -71.18 -110.36 REMARK 500 LYS C 146 -151.87 -37.83 REMARK 500 LYS C 147 -93.64 -153.51 REMARK 500 ASP C 149 66.95 -24.23 REMARK 500 GLN C 159 63.72 69.19 REMARK 500 GLU D 20 -94.34 -159.15 REMARK 500 ASN D 22 -19.24 124.46 REMARK 500 MET D 29 -149.24 -161.22 REMARK 500 LYS D 35 132.34 -173.08 REMARK 500 ASP D 36 -111.78 49.14 REMARK 500 THR D 121 -155.08 -137.08 REMARK 500 THR D 122 104.65 -163.57 REMARK 500 THR D 156 -165.91 -115.75 REMARK 500 VAL D 157 133.58 -171.25 REMARK 500 GLN D 159 79.92 57.79 REMARK 500 ILE D 216 62.31 68.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU A 132 -10.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: N-(IODOACETYL)-L-VALYL-L-PHENYLALANINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 IVF A 301 REMARK 630 IVF B 301 REMARK 630 IVF C 301 REMARK 630 IVF D 301 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 04E VAL PHE NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IVF A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IVF B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IVF C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IVF D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS D 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D 303 DBREF 1QA7 A 1 217 UNP P26582 POLG_HPAV8 1519 1735 DBREF 1QA7 B 1 217 UNP P26582 POLG_HPAV8 1519 1735 DBREF 1QA7 C 1 217 UNP P26582 POLG_HPAV8 1519 1735 DBREF 1QA7 D 1 217 UNP P26582 POLG_HPAV8 1519 1735 SEQADV 1QA7 SER A 24 UNP P26582 CYS 1542 ENGINEERED MUTATION SEQADV 1QA7 ALA A 82 UNP P26582 PHE 1600 ENGINEERED MUTATION SEQADV 1QA7 GLN A 101 UNP P26582 GLU 1619 CONFLICT SEQADV 1QA7 SER B 24 UNP P26582 CYS 1542 ENGINEERED MUTATION SEQADV 1QA7 ALA B 82 UNP P26582 PHE 1600 ENGINEERED MUTATION SEQADV 1QA7 GLN B 101 UNP P26582 GLU 1619 CONFLICT SEQADV 1QA7 SER C 24 UNP P26582 CYS 1542 ENGINEERED MUTATION SEQADV 1QA7 ALA C 82 UNP P26582 PHE 1600 ENGINEERED MUTATION SEQADV 1QA7 GLN C 101 UNP P26582 GLU 1619 CONFLICT SEQADV 1QA7 SER D 24 UNP P26582 CYS 1542 ENGINEERED MUTATION SEQADV 1QA7 ALA D 82 UNP P26582 PHE 1600 ENGINEERED MUTATION SEQADV 1QA7 GLN D 101 UNP P26582 GLU 1619 CONFLICT SEQRES 1 A 217 SER THR LEU GLU ILE ALA GLY LEU VAL ARG LYS ASN LEU SEQRES 2 A 217 VAL GLN PHE GLY VAL GLY GLU LYS ASN GLY SER VAL ARG SEQRES 3 A 217 TRP VAL MET ASN ALA LEU GLY VAL LYS ASP ASP TRP LEU SEQRES 4 A 217 LEU VAL PRO SER HIS ALA TYR LYS PHE GLU LYS ASP TYR SEQRES 5 A 217 GLU MET MET GLU PHE TYR PHE ASN ARG GLY GLY THR TYR SEQRES 6 A 217 TYR SER ILE SER ALA GLY ASN VAL VAL ILE GLN SER LEU SEQRES 7 A 217 ASP VAL GLY ALA GLN ASP VAL VAL LEU MET LYS VAL PRO SEQRES 8 A 217 THR ILE PRO LYS PHE ARG ASP ILE THR GLN HIS PHE ILE SEQRES 9 A 217 LYS LYS GLY ASP VAL PRO ARG ALA LEU ASN ARG LEU ALA SEQRES 10 A 217 THR LEU VAL THR THR VAL ASN GLY THR PRO MET LEU ILE SEQRES 11 A 217 SER GLU GLY PRO LEU LYS MET GLU GLU LYS ALA THR TYR SEQRES 12 A 217 VAL HIS LYS LYS ASN ASP GLY THR THR VAL ASP LEU THR SEQRES 13 A 217 VAL ASP GLN ALA TRP ARG GLY LYS GLY GLU GLY LEU PRO SEQRES 14 A 217 GLY MET CYS GLY GLY ALA LEU VAL SER SER ASN GLN SER SEQRES 15 A 217 ILE GLN ASN ALA ILE LEU GLY ILE HIS VAL ALA GLY GLY SEQRES 16 A 217 ASN SER ILE LEU VAL ALA LYS LEU VAL THR GLN GLU MET SEQRES 17 A 217 PHE GLN ASN ILE ASP LYS LYS ILE GLU SEQRES 1 B 217 SER THR LEU GLU ILE ALA GLY LEU VAL ARG LYS ASN LEU SEQRES 2 B 217 VAL GLN PHE GLY VAL GLY GLU LYS ASN GLY SER VAL ARG SEQRES 3 B 217 TRP VAL MET ASN ALA LEU GLY VAL LYS ASP ASP TRP LEU SEQRES 4 B 217 LEU VAL PRO SER HIS ALA TYR LYS PHE GLU LYS ASP TYR SEQRES 5 B 217 GLU MET MET GLU PHE TYR PHE ASN ARG GLY GLY THR TYR SEQRES 6 B 217 TYR SER ILE SER ALA GLY ASN VAL VAL ILE GLN SER LEU SEQRES 7 B 217 ASP VAL GLY ALA GLN ASP VAL VAL LEU MET LYS VAL PRO SEQRES 8 B 217 THR ILE PRO LYS PHE ARG ASP ILE THR GLN HIS PHE ILE SEQRES 9 B 217 LYS LYS GLY ASP VAL PRO ARG ALA LEU ASN ARG LEU ALA SEQRES 10 B 217 THR LEU VAL THR THR VAL ASN GLY THR PRO MET LEU ILE SEQRES 11 B 217 SER GLU GLY PRO LEU LYS MET GLU GLU LYS ALA THR TYR SEQRES 12 B 217 VAL HIS LYS LYS ASN ASP GLY THR THR VAL ASP LEU THR SEQRES 13 B 217 VAL ASP GLN ALA TRP ARG GLY LYS GLY GLU GLY LEU PRO SEQRES 14 B 217 GLY MET CYS GLY GLY ALA LEU VAL SER SER ASN GLN SER SEQRES 15 B 217 ILE GLN ASN ALA ILE LEU GLY ILE HIS VAL ALA GLY GLY SEQRES 16 B 217 ASN SER ILE LEU VAL ALA LYS LEU VAL THR GLN GLU MET SEQRES 17 B 217 PHE GLN ASN ILE ASP LYS LYS ILE GLU SEQRES 1 C 217 SER THR LEU GLU ILE ALA GLY LEU VAL ARG LYS ASN LEU SEQRES 2 C 217 VAL GLN PHE GLY VAL GLY GLU LYS ASN GLY SER VAL ARG SEQRES 3 C 217 TRP VAL MET ASN ALA LEU GLY VAL LYS ASP ASP TRP LEU SEQRES 4 C 217 LEU VAL PRO SER HIS ALA TYR LYS PHE GLU LYS ASP TYR SEQRES 5 C 217 GLU MET MET GLU PHE TYR PHE ASN ARG GLY GLY THR TYR SEQRES 6 C 217 TYR SER ILE SER ALA GLY ASN VAL VAL ILE GLN SER LEU SEQRES 7 C 217 ASP VAL GLY ALA GLN ASP VAL VAL LEU MET LYS VAL PRO SEQRES 8 C 217 THR ILE PRO LYS PHE ARG ASP ILE THR GLN HIS PHE ILE SEQRES 9 C 217 LYS LYS GLY ASP VAL PRO ARG ALA LEU ASN ARG LEU ALA SEQRES 10 C 217 THR LEU VAL THR THR VAL ASN GLY THR PRO MET LEU ILE SEQRES 11 C 217 SER GLU GLY PRO LEU LYS MET GLU GLU LYS ALA THR TYR SEQRES 12 C 217 VAL HIS LYS LYS ASN ASP GLY THR THR VAL ASP LEU THR SEQRES 13 C 217 VAL ASP GLN ALA TRP ARG GLY LYS GLY GLU GLY LEU PRO SEQRES 14 C 217 GLY MET CYS GLY GLY ALA LEU VAL SER SER ASN GLN SER SEQRES 15 C 217 ILE GLN ASN ALA ILE LEU GLY ILE HIS VAL ALA GLY GLY SEQRES 16 C 217 ASN SER ILE LEU VAL ALA LYS LEU VAL THR GLN GLU MET SEQRES 17 C 217 PHE GLN ASN ILE ASP LYS LYS ILE GLU SEQRES 1 D 217 SER THR LEU GLU ILE ALA GLY LEU VAL ARG LYS ASN LEU SEQRES 2 D 217 VAL GLN PHE GLY VAL GLY GLU LYS ASN GLY SER VAL ARG SEQRES 3 D 217 TRP VAL MET ASN ALA LEU GLY VAL LYS ASP ASP TRP LEU SEQRES 4 D 217 LEU VAL PRO SER HIS ALA TYR LYS PHE GLU LYS ASP TYR SEQRES 5 D 217 GLU MET MET GLU PHE TYR PHE ASN ARG GLY GLY THR TYR SEQRES 6 D 217 TYR SER ILE SER ALA GLY ASN VAL VAL ILE GLN SER LEU SEQRES 7 D 217 ASP VAL GLY ALA GLN ASP VAL VAL LEU MET LYS VAL PRO SEQRES 8 D 217 THR ILE PRO LYS PHE ARG ASP ILE THR GLN HIS PHE ILE SEQRES 9 D 217 LYS LYS GLY ASP VAL PRO ARG ALA LEU ASN ARG LEU ALA SEQRES 10 D 217 THR LEU VAL THR THR VAL ASN GLY THR PRO MET LEU ILE SEQRES 11 D 217 SER GLU GLY PRO LEU LYS MET GLU GLU LYS ALA THR TYR SEQRES 12 D 217 VAL HIS LYS LYS ASN ASP GLY THR THR VAL ASP LEU THR SEQRES 13 D 217 VAL ASP GLN ALA TRP ARG GLY LYS GLY GLU GLY LEU PRO SEQRES 14 D 217 GLY MET CYS GLY GLY ALA LEU VAL SER SER ASN GLN SER SEQRES 15 D 217 ILE GLN ASN ALA ILE LEU GLY ILE HIS VAL ALA GLY GLY SEQRES 16 D 217 ASN SER ILE LEU VAL ALA LYS LEU VAL THR GLN GLU MET SEQRES 17 D 217 PHE GLN ASN ILE ASP LYS LYS ILE GLU HET IVF A 301 22 HET IVF B 301 22 HET IVF C 301 22 HET IVF D 301 22 HET DMS D 302 4 HET GOL D 303 6 HETNAM IVF N-(IODOACETYL)-L-VALYL-L-PHENYLALANINAMIDE HETNAM DMS DIMETHYL SULFOXIDE HETNAM GOL GLYCEROL HETSYN IVF IODOACETYL-VALYL-PHENYLALANYL-AMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 IVF 4(C16 H22 I N3 O3) FORMUL 9 DMS C2 H6 O S FORMUL 10 GOL C3 H8 O3 FORMUL 11 HOH *514(H2 O) HELIX 1 1 SER A 1 LYS A 11 1 11 HELIX 2 2 HIS A 44 TYR A 46 5 3 HELIX 3 3 ILE A 99 HIS A 102 5 4 HELIX 4 4 LYS A 105 ALA A 112 5 8 HELIX 5 5 ASN A 180 GLN A 184 5 5 HELIX 6 6 THR A 205 ILE A 212 5 8 HELIX 7 7 SER B 1 ASN B 12 1 12 HELIX 8 8 HIS B 44 TYR B 46 5 3 HELIX 9 9 GLY B 71 VAL B 73 5 3 HELIX 10 10 ILE B 99 HIS B 102 5 4 HELIX 11 11 ASP B 108 LEU B 113 5 6 HELIX 12 12 ASN B 180 GLN B 184 5 5 HELIX 13 13 GLN B 206 GLN B 210 5 5 HELIX 14 14 SER C 1 ASN C 12 1 12 HELIX 15 15 HIS C 44 TYR C 46 5 3 HELIX 16 16 ASP C 51 MET C 54 5 4 HELIX 17 17 GLY C 71 VAL C 73 5 3 HELIX 18 18 ILE C 99 HIS C 102 5 4 HELIX 19 19 LYS C 105 ALA C 112 5 8 HELIX 20 20 ASN C 180 GLN C 184 5 5 HELIX 21 21 GLN C 206 ILE C 212 5 7 HELIX 22 22 SER D 1 ASN D 12 1 12 HELIX 23 23 HIS D 44 TYR D 46 5 3 HELIX 24 24 GLY D 71 VAL D 73 5 3 HELIX 25 25 ILE D 99 HIS D 102 5 4 HELIX 26 26 LYS D 105 LEU D 113 5 9 HELIX 27 27 ASN D 180 GLN D 184 5 5 HELIX 28 28 THR D 205 GLN D 210 5 6 SHEET 1 A 7 THR A 64 SER A 69 0 SHEET 2 A 7 GLU A 56 ARG A 61 -1 N PHE A 57 O ILE A 68 SHEET 3 A 7 LEU A 13 GLY A 19 -1 O GLN A 15 N ASN A 60 SHEET 4 A 7 ARG A 26 LYS A 35 -1 O ARG A 26 N VAL A 18 SHEET 5 A 7 TRP A 38 PRO A 42 -1 O TRP A 38 N VAL A 34 SHEET 6 A 7 VAL A 85 LYS A 89 -1 O VAL A 86 N VAL A 41 SHEET 7 A 7 ILE A 75 SER A 77 -1 N GLN A 76 O LEU A 87 SHEET 1 B 7 PRO A 127 GLU A 132 0 SHEET 2 B 7 ALA A 117 THR A 122 -1 N ALA A 117 O GLU A 132 SHEET 3 B 7 ALA A 175 SER A 178 -1 O ALA A 175 N VAL A 120 SHEET 4 B 7 ILE A 187 GLY A 195 -1 N LEU A 188 O LEU A 176 SHEET 5 B 7 ILE A 198 LEU A 203 -1 O ILE A 198 N GLY A 195 SHEET 6 B 7 ASP A 154 LYS A 164 -1 O GLN A 159 N LEU A 203 SHEET 7 B 7 LYS A 136 VAL A 144 -1 N LYS A 136 O ARG A 162 SHEET 1 C 7 THR B 64 SER B 69 0 SHEET 2 C 7 GLU B 56 ARG B 61 -1 N PHE B 57 O ILE B 68 SHEET 3 C 7 LEU B 13 GLY B 19 -1 O GLN B 15 N ASN B 60 SHEET 4 C 7 VAL B 25 LYS B 35 -1 N ARG B 26 O VAL B 18 SHEET 5 C 7 TRP B 38 PRO B 42 -1 N TRP B 38 O LYS B 35 SHEET 6 C 7 VAL B 85 LYS B 89 -1 O VAL B 86 N VAL B 41 SHEET 7 C 7 VAL B 74 SER B 77 -1 O VAL B 74 N LYS B 89 SHEET 1 D 7 THR B 126 SER B 131 0 SHEET 2 D 7 ALA B 117 VAL B 123 -1 N LEU B 119 O ILE B 130 SHEET 3 D 7 ALA B 175 SER B 178 -1 O ALA B 175 N VAL B 120 SHEET 4 D 7 ILE B 187 GLY B 195 -1 N LEU B 188 O LEU B 176 SHEET 5 D 7 ILE B 198 LEU B 203 -1 O ILE B 198 N GLY B 195 SHEET 6 D 7 ASP B 154 LYS B 164 -1 O GLN B 159 N LEU B 203 SHEET 7 D 7 LYS B 136 VAL B 144 -1 O LYS B 136 N ARG B 162 SHEET 1 E 7 THR C 64 SER C 69 0 SHEET 2 E 7 GLU C 56 ARG C 61 -1 N PHE C 57 O ILE C 68 SHEET 3 E 7 LEU C 13 GLY C 19 -1 O GLN C 15 N ASN C 60 SHEET 4 E 7 ARG C 26 LYS C 35 -1 N ARG C 26 O VAL C 18 SHEET 5 E 7 TRP C 38 PRO C 42 -1 N TRP C 38 O LYS C 35 SHEET 6 E 7 VAL C 85 LYS C 89 -1 N VAL C 86 O VAL C 41 SHEET 7 E 7 VAL C 74 SER C 77 -1 O VAL C 74 N LYS C 89 SHEET 1 F 8 LYS C 136 VAL C 144 0 SHEET 2 F 8 ASP C 154 LYS C 164 -1 O LEU C 155 N TYR C 143 SHEET 3 F 8 ILE C 198 LEU C 203 -1 N LEU C 199 O GLY C 163 SHEET 4 F 8 ILE C 187 GLY C 195 -1 O ILE C 190 N LYS C 202 SHEET 5 F 8 ALA C 175 SER C 178 -1 O LEU C 176 N LEU C 188 SHEET 6 F 8 ALA C 117 THR C 122 -1 N THR C 118 O VAL C 177 SHEET 7 F 8 PRO C 127 GLU C 132 -1 N MET C 128 O THR C 121 SHEET 8 F 8 GLY D 81 ALA D 82 -1 N GLY D 81 O SER C 131 SHEET 1 G 7 THR D 64 SER D 69 0 SHEET 2 G 7 GLU D 56 ARG D 61 -1 N PHE D 57 O ILE D 68 SHEET 3 G 7 LEU D 13 GLY D 19 -1 O GLN D 15 N ASN D 60 SHEET 4 G 7 VAL D 25 LYS D 35 -1 O ARG D 26 N VAL D 18 SHEET 5 G 7 TRP D 38 PRO D 42 -1 N TRP D 38 O LYS D 35 SHEET 6 G 7 VAL D 85 LYS D 89 -1 N VAL D 86 O VAL D 41 SHEET 7 G 7 VAL D 74 GLN D 76 -1 O VAL D 74 N LYS D 89 SHEET 1 H 7 THR D 126 GLU D 132 0 SHEET 2 H 7 ALA D 117 VAL D 123 -1 N ALA D 117 O GLU D 132 SHEET 3 H 7 ALA D 175 SER D 178 -1 O ALA D 175 N VAL D 120 SHEET 4 H 7 ILE D 187 GLY D 195 -1 N LEU D 188 O LEU D 176 SHEET 5 H 7 ILE D 198 LEU D 203 -1 N ILE D 198 O GLY D 195 SHEET 6 H 7 THR D 152 LYS D 164 -1 O GLN D 159 N LEU D 203 SHEET 7 H 7 LYS D 136 LYS D 146 -1 N LYS D 136 O ARG D 162 LINK SG CYS A 172 CH3 IVF A 301 1555 1555 1.96 LINK SG CYS B 172 CH3 IVF B 301 1555 1555 1.75 LINK SG CYS C 172 CH3 IVF C 301 1555 1555 1.93 LINK SG CYS D 172 CH3 IVF D 301 1555 1555 1.92 CISPEP 1 GLY A 133 PRO A 134 0 -1.87 CISPEP 2 GLY B 133 PRO B 134 0 1.31 CISPEP 3 GLY C 133 PRO C 134 0 5.40 CISPEP 4 GLY D 133 PRO D 134 0 2.36 SITE 1 AC1 11 GLN A 15 TRP A 27 VAL A 28 MET A 29 SITE 2 AC1 11 THR A 122 ASN A 124 HIS A 145 PRO A 169 SITE 3 AC1 11 GLY A 170 MET A 171 CYS A 172 SITE 1 AC2 9 VAL B 28 HIS B 44 ASN B 124 PRO B 169 SITE 2 AC2 9 GLY B 170 MET B 171 CYS B 172 HOH B2127 SITE 3 AC2 9 LYS C 106 SITE 1 AC3 10 TRP C 27 VAL C 28 MET C 29 LYS C 147 SITE 2 AC3 10 PRO C 169 GLY C 170 MET C 171 CYS C 172 SITE 3 AC3 10 HOH C3047 HOH C3120 SITE 1 AC4 10 LYS A 106 GLN D 15 VAL D 28 MET D 29 SITE 2 AC4 10 THR D 122 ASN D 124 GLY D 170 MET D 171 SITE 3 AC4 10 CYS D 172 HOH D4107 SITE 1 AC5 3 LYS D 136 ARG D 162 ILE D 198 SITE 1 AC6 7 ALA A 70 GLY A 71 VAL A 73 HOH A1042 SITE 2 AC6 7 LEU D 3 ARG D 10 LEU D 129 CRYST1 50.562 78.357 105.287 90.00 97.50 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019778 0.000000 0.002604 0.00000 SCALE2 0.000000 0.012762 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009580 0.00000